Skip to main content

FRIDAY, NOVEMBER 15, 2024 | 10:00AM-4:00PM ET | VIRTUAL EVENT

SCIENTIFIC SYMPOSIUM

Tune in for discussions on the latest updates from leading C. diff experts in the areas of treatment, prevention, and epidemiology.

LEARN FROM LEADING C. DIFF EXPERTS

In the spirit of education and collaboration, we’re excited to announce our inaugural “Scientific Symposium,” debuting on Friday, November 15th, 2024. This virtual event will allow clinicians, scientists, nurses, pharmacists, and industry to intermingle and update each other during C. diff Awareness Month. The Symposium will also feature testimonials from C. diff patients and survivors.

Confirmed Speakers

  • Epidemiology: Defining the Problem
    Alice Guh, MD, MPH

  • Diagnosis of CDI
    Erik Dubberke, MD, MSPH

  • Novel Small Molecule Treatment, REC-3964
    Andrew Skinner, MD

  • Pathophysiology of C. difficile
    Bruce Hirsch, MD

  • Risk Factors for CDI
    Vincent Young, MD, PhD

  • Pediatric C. diff
    Maribeth Nicholson, MD, MPH

  • Infection Control
    Cindy Hou, DO, MA, MBA, CIC, CPHQ, CPPS, FACOI, FACP, FIDSA, FAPIC

  • Panel Discussion: The IDSA vs. ACG Guidelines for Antimicrobial Management of CDI
    Paul Feuerstadt, MD, FACG, AGAF
    Colleen Kelly, MD
    Stuart Johnson, MD

  • Introduction to the Microbiota; FMT vs. LBP
    Glenn Tillotson, PhD,  FIDSA, FCCP

  • Fecal Microbiota, Live-JSLM
    Sahil Khanna, MD, MBBS, MS, FACG, AGAF

  • RePreve: A pivotal trial of Lumen Bio’s new low-cost, convenient C. difficile preventative
    Carl Mason, MD, MPH

  • Ibezapolstat Preserves Key Clostridium leptum Species
    Kevin Garey, PharmD

  • Fecal Microbiota Spores, Live-BRPK
    Jessica Allegretti, MD, MPH

  • Vowst Manufacturing: From donor-derived microbiota to Fimicutes capsules
    Jason Goldsmith, MD, PhD

  • Enzyme Immunoassay (EIA) CDI diagnostic testing
    Stuart Cohen, MD

  • Health-Related Quality of Life with CDI
    Christian John Lillis

  • Vedanta’s Clinical Trials to prevent recurrent C. Diff Infections-Transforming the field with First Live Biotherapeutic Products
    Steven Shiff, MD

  • CRS3123:  A Narrow Spectrum Agent for Treatment of CDI
    Jon B. Bruss, MD, MSPH, MBA

  • ProbioTech USA biosciences: The Next Generation of Rx LBP – Present and Future
    Sahil Khanna, MD, MBBS, MS, FACG, AGAF


SPONSOR THE SYMPOSIUM

View the event’s sponsorship prospectus here and contact Erin at erin@peggyfoundation.org for more information about sponsoring the Symposium.

PLATINUM SPONSOR

GOLD SPONSORS

SILVER SPONSORS

bronze sponsors